These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11998370)

  • 21. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a flow cytometric bead immunoassay and its assessment as a possible aid to potency evaluation of enterotoxaemia vaccines.
    Buys A; Macdonald R; Crafford J; Theron J
    J S Afr Vet Assoc; 2014 Mar; 85(1):977. PubMed ID: 24832497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective effect of Clostridium novyi type B alpha-toxoid against challenge with spores in guinea pigs.
    Amimoto K; Sasaki O; Isogai M; Kitajima T; Oishi E; Okada N; Yasuhara H
    J Vet Med Sci; 1998 Jun; 60(6):681-5. PubMed ID: 9673937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the in vitro neutralization test of Clostridium perfringens type A toxin.
    Shemanova GF; Vlasova EV; Postnikova TM
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opportunities to reduce the use of animals in the potency and toxicity testing of toxoid vaccines.
    Knight PA
    Dev Biol Stand; 1996; 86():185-97. PubMed ID: 8785948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W; Bisesti E; Pereyra JB; Iribarren F
    Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera.
    Hendriksen CF; vd Gun JW; Nagel J; Kreeftenberg JG
    J Biol Stand; 1988 Oct; 16(4):287-97. PubMed ID: 3198659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.
    Ebert E; Kusch M; Öppling V; Werner E; Cussler K
    ALTEX; 1996; 13(2):68-75. PubMed ID: 11178445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
    Rosskopf-Streicher U; Volkers P; Werner E
    Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic variation and cross-reactivity of Clostridium septicum alpha-toxin.
    Amimoto K; Sasaki Y; Fukuyama S; Tamura Y
    Vet Microbiol; 2006 Apr; 114(1-2):51-9. PubMed ID: 16337096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of neutralizing antibodies against alpha-toxin of different Clostridium septicum strains in cell culture.
    Roth F; Jansen K; Petzke S
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):353-9. PubMed ID: 10397322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies.
    Maruta T; Dolimbek BZ; Aoki KR; Atassi MZ
    J Neurosci Methods; 2006 Mar; 151(2):90-6. PubMed ID: 16466805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass production and standardization of Clostridium oedematiens vaccine against black disease (infectious necrotic hepatitis) of sheep.
    Ardehali M; Darakhshan H; Moosawi M
    Dev Biol Stand; 1986; 64():137-40. PubMed ID: 3792643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of toxin neutralisation in test systems for diphtheria antibody assessment.
    Vandenberg J; van der Gun JW; Hendriksen CF
    Dev Biol Stand; 1999; 101():105-11. PubMed ID: 10566782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro assays for botulinum toxin and antitoxins.
    Shone C; Appleton N; Wilton-Smith P; Hambleton P; Modi N; Gatley S; Melling J
    Dev Biol Stand; 1986; 64():141-5. PubMed ID: 3792644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.